{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:12:33Z","timestamp":1778915553646,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["159980\/2012-7"],"award-info":[{"award-number":["159980\/2012-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005288","name":"Fapesp","doi-asserted-by":"publisher","award":["471380\/2008-13."],"award-info":[{"award-number":["471380\/2008-13."]}],"id":[{"id":"10.13039\/501100005288","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.gene.2015.05.074","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T09:13:47Z","timestamp":1433582027000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Asymptomatic individuals with high HDL-C levels overexpress ABCA1 and ABCG1 and present miR-33a dysregulation in peripheral blood mononuclear cells"],"prefix":"10.1016","volume":"570","author":[{"given":"D.Z.","family":"Scherrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2488-0199","authenticated-orcid":false,"given":"V.H.S.","family":"Zago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.S.","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Avansini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.B.","family":"Panzoldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Baracat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.R.","family":"Nakandakare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.C.R.","family":"Quint\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.C.","family":"de Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2015.05.074_bb0005","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1038\/cddis.2013.301","article-title":"Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRalpha expression and cholesterol homeostasis","volume":"4","author":"Adlakha","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2015.05.074_bb0010","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/emmm.201201228","article-title":"miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity","volume":"4","author":"Allen","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.gene.2015.05.074_bb0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.atherosclerosis.2007.07.033","article-title":"High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review","volume":"196","author":"Amarenco","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.gene.2015.05.074_bb0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.gene.2015.05.074_bb0025","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/oby.2011.38","article-title":"A better index of body adiposity","volume":"19","author":"Bergman","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.gene.2015.05.074_bb0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/cvr\/cvu140","article-title":"microRNAs and HDL life cycle","volume":"103","author":"Canfran-Duque","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.gene.2015.05.074_bb0035","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.2337\/dc06-0070","article-title":"New insights on the simultaneous assessment of insulin sensitivity and beta-cell function with the HOMA2 method","volume":"29","author":"Caumo","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.gene.2015.05.074_bb0040","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)35376-1","article-title":"A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum","volume":"22","author":"Chapman","year":"1981","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2015.05.074_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2012.11.025","article-title":"MicroRNA-33 in atherosclerosis etiology and pathophysiology","volume":"227","author":"Chen","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.gene.2015.05.074_bb0050","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/BF00400586","article-title":"Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM","volume":"38","author":"Cummings","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.gene.2015.05.074_bb0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phrs.2013.02.005","article-title":"From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport","volume":"75","author":"Davalos","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.gene.2015.05.074_bb0060","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1093\/clinchem\/34.11.2322","article-title":"Dual-precipitation method evaluated for determination of high-density lipoprotein (HDL), HDL2, and HDL3 cholesterol concentrations","volume":"34","author":"Dias","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.gene.2015.05.074_bb0065","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0022-2275(20)41395-1","article-title":"Cholesterol esterification rate in plasma depleted of very low and low density lipoproteins is controlled by the proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men","volume":"33","author":"Dobiasova","year":"1992","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2015.05.074_bb0070","first-page":"685","article-title":"Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study","volume":"30","author":"Duvillard","year":"2000","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.gene.2015.05.074_bb0075","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0076-6879(86)29101-6","article-title":"Preparation, characterization, and measurement of hepatic lipase","volume":"129","author":"Ehnholm","year":"1986","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.gene.2015.05.074_bb0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/MOL.0b013e3283428d9d","article-title":"MicroRNAs in lipid metabolism","volume":"22","author":"Fernandez-Hernando","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.gene.2015.05.074_bb0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.gene.2015.05.074_bb0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.gene.2015.05.074_bb0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","article-title":"MicroRNA targeting specificity in mammals: determinants beyond seed pairing","volume":"27","author":"Grimson","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.gene.2015.05.074_bb0100","doi-asserted-by":"crossref","first-page":"e78241","DOI":"10.1371\/journal.pone.0078241","article-title":"Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype","volume":"8","author":"Holven","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2015.05.074_bb0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0021-9150(99)00429-3","article-title":"Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity","volume":"151","author":"Huuskonen","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.gene.2015.05.074_bb0110","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1016\/S0021-9258(19)62718-3","article-title":"Human plasma lecithin-cholesterol acyltransferase. An elucidation of the catalytic mechanism","volume":"261","author":"Jauhiainen","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2015.05.074_bb0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ymeth.2004.11.006","article-title":"Determination of human plasma phospholipid transfer protein mass and activity","volume":"36","author":"Jauhiainen","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.gene.2015.05.074_bb0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2261-5-26","article-title":"The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison","volume":"5","author":"Kahn","year":"2005","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.gene.2015.05.074_bb0125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2337\/diab.43.3.411","article-title":"Isolated low HDL cholesterol. An insulin-resistant state","volume":"43","author":"Karhapaa","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.gene.2015.05.074_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2337\/diab.31.3.217","article-title":"Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus","volume":"31","author":"Kissebah","year":"1982","journal-title":"Diabetes"},{"key":"10.1016\/j.gene.2015.05.074_bb0135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0021-9150(01)00594-9","article-title":"Dietary determinants of serum paraoxonase activity in healthy humans","volume":"160","author":"Kleemola","year":"2002","journal-title":"Atherosclerosis"},{"issue":"Suppl. 4","key":"10.1016\/j.gene.2015.05.074_bb0140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1463-1326.2009.01118.x","article-title":"Role and therapeutic potential of microRNAs in diabetes","volume":"11","author":"Kolfschoten","year":"2009","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.gene.2015.05.074_bb0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.gene.2015.05.074_bb0150","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2015.05.074_bb0155","first-page":"231","article-title":"Determination of the mass concentration and the activity of the plasma cholesteryl ester transfer protein (CETP)","volume":"110","author":"Lagrost","year":"1998","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.gene.2015.05.074_bb0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1475-2840-12-173","article-title":"Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects","volume":"12","author":"Leanca","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.gene.2015.05.074_bb0165","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.gene.2015.05.074_bb0170","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1373\/clinchem.2004.032383","article-title":"Rapid, simple laser-light-scattering method for HDL particle sizing in whole plasma","volume":"50","author":"Lima","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.gene.2015.05.074_bb0175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.gene.2015.05.074_bb0180","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1089\/dna.2012.1940","article-title":"Posttranscriptional regulation of ATP-binding cassette transporter A1 in lipid metabolism","volume":"32","author":"Lv","year":"2013","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.gene.2015.05.074_bb0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/dmrr.2362","article-title":"Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1-mediated reverse cholesterol transport","volume":"29","author":"Machado-Lima","year":"2013","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.gene.2015.05.074_bb0190","doi-asserted-by":"crossref","first-page":"12228","DOI":"10.1073\/pnas.1005191107","article-title":"miR-33 links SREBP-2 induction to repression of sterol transporters","volume":"107","author":"Marquart","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2015.05.074_bb0195","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/ATVBAHA.112.300639","article-title":"Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"33","author":"Marquart","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gene.2015.05.074_bb0200","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.tem.2010.08.008","article-title":"microRNAs and cholesterol metabolism","volume":"21","author":"Moore","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.gene.2015.05.074_bb0205","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1189123","article-title":"MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis","volume":"328","author":"Najafi-Shoushtari","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.gene.2015.05.074_bb0210","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2011.02.021","article-title":"Insulin down-regulates specific activity of ATP-binding cassette transporter A1 for high density lipoprotein biogenesis through its specific phosphorylation","volume":"216","author":"Nonomura","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.gene.2015.05.074_bb0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nri2708","article-title":"Physiological and pathological roles for microRNAs in the immune system","volume":"10","author":"O'Connell","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.gene.2015.05.074_bb0220","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0022-2275(20)31998-2","article-title":"Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive","volume":"41","author":"Oka","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2015.05.074_bb0225","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1194\/jlr.M100349-JLR200","article-title":"Distribution of human plasma PLTP mass and activity in hypo- and hyperalphalipoproteinemia","volume":"43","author":"Oka","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2015.05.074_bb0230","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/jpet.103.048991","article-title":"Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes","volume":"306","author":"Ouguerram","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.gene.2015.05.074_bb0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1590\/S1676-24442013000100004","article-title":"Development of a clinical laboratory data base of hyper and hypo alpha lipoproteins in Campinas-SP and neighboring region","volume":"49","author":"Parra","year":"2013","journal-title":"J. Bras. Patol. Med. Lab."},{"key":"10.1016\/j.gene.2015.05.074_bb0240","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0009-9120(03)00078-X","article-title":"Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity","volume":"36","author":"Rashid","year":"2003","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.gene.2015.05.074_bb0245","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCRESAHA.114.300645","article-title":"MicroRNA control of high-density lipoprotein metabolism and function","volume":"114","author":"Rayner","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.gene.2015.05.074_bb0250","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.gene.2015.05.074_bb0255","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature10486","article-title":"Inhibition of miR-33a\/b in non-human primates raises plasma HDL and lowers VLDL triglycerides","volume":"478","author":"Rayner","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.gene.2015.05.074_bb0260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00041433-200406000-00006","article-title":"High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease","volume":"15","author":"Rohrer","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.gene.2015.05.074_bb0265","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/ATVBAHA.113.301732","article-title":"Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr\u2212\/\u2212 mice\u2014brief report","volume":"33","author":"Rotllan","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gene.2015.05.074_bb0270","doi-asserted-by":"crossref","first-page":"212ra162","DOI":"10.1126\/scitranslmed.3006840","article-title":"Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR","volume":"5","author":"Rottiers","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.gene.2015.05.074_bb0275","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/01.CIR.100.9.951","article-title":"Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease)","volume":"100","author":"Simons","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.gene.2015.05.074_bb0280","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-0034-1374600","article-title":"Regulation of ATP-binding cassette transporters and cholesterol efflux by glucose in primary human monocytes and murine bone marrow-derived macrophages","volume":"122","author":"Spartano","year":"2014","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.gene.2015.05.074_bb0285","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2796.2007.01898.x","article-title":"Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins","volume":"263","author":"Tall","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.gene.2015.05.074_bb0290","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cmet.2008.03.001","article-title":"HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis","volume":"7","author":"Tall","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.gene.2015.05.074_bb0295","doi-asserted-by":"crossref","first-page":"21090","DOI":"10.1074\/jbc.M701228200","article-title":"Sterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status","volume":"282","author":"Tamehiro","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2015.05.074_bb0300","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1073\/pnas.200367697","article-title":"Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha","volume":"97","author":"Venkateswaran","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2015.05.074_bb0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MOL.0b013e3283412279","article-title":"Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2","volume":"22","author":"von Eckardstein","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.gene.2015.05.074_bb0310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.ATV.21.1.13","article-title":"High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport","volume":"21","author":"von Eckardstein","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gene.2015.05.074_bb0315","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1194\/jlr.R004739","article-title":"Genetic causes of high and low serum HDL-cholesterol","volume":"51","author":"Weissglas-Volkov","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2015.05.074_bb0320","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","article-title":"Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans","volume":"75","author":"Wightman","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.gene.2015.05.074_bb0325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1253\/circj.68.11","article-title":"Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases","volume":"68","author":"Yatsuya","year":"2004","journal-title":"Circ. J."},{"key":"10.1016\/j.gene.2015.05.074_bb0330","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.ATV.0000195789.39418.e8","article-title":"Assembly of high-density lipoprotein","volume":"26","author":"Yokoyama","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111915007064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111915007064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:51:30Z","timestamp":1778914290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111915007064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0378111915007064"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2015.05.074","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymptomatic individuals with high HDL-C levels overexpress ABCA1 and ABCG1 and present miR-33a dysregulation in peripheral blood mononuclear cells","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2015.05.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}